Advanced Drug Delivery Technologies
Enabling Drug Reformulations and Administration Routes
Exciting developments are occurring in the field of alternative drug delivery—a phrase that describes the reformulation of drugs to enable lower doses, more convenient delivery routes, and supplemental therapeutic indications.... |
Global Pharmaceutical Product Lifecycle Management Forecast 2006-2012 (Interactive Model)
Introduction
Streamlining product development processes is becoming a major priority for pharmaceutical manufacturers looking to improve their market share, and respond to growing regulatory pressure and competition. This Datamonitor model forecasts... |
Pharmaceutical Product Lifecycle Management
2010-2020
Where will the greatest challenges and opportunities lie this decade, and what does the future hold?
The pharmaceutical industry currently faces marked challenges in its long-standing business model. Product lifecycle management... |
Managing Process Complexity in the Pharmaceutical Industry with PLM (Strategy Focus)
Introduction
Product lifecycle management (PLM) software and services solutions are still a nascent market for the pharmaceutical industry. Datamonitor believes that unless the industry adopts a strategic approach to PLM, the... |
Pharma Marketing ROI
Caught in a tightening vice between declining new product introductions and accelerating patent erosion, the pharmaceutical industry has been cutting back spending across the board to improve profits. Conversely, marketing... |
Pharmaceutical Product Lifecycle Management Forecast in Western Europe 2006-2012 (Databook)
Introduction
This databook provides readers with an overview of IT spending on PLM software and services in Western Europe, including France, Germany, the UK, Spain, Italy and Switzerland.
Scope
Current and projected IT... |
Optimizing PLM Technology for the Pharmaceutical Industry (Technology Focus)
Introduction
Datamonitor views product lifecycle management (PLM) technology as one of the most rapidly growing market in the pharmaceutical industry due to its inherent focus on time to market and product... |
From Idea to Market: Product Lifecycle Management in the Pharmaceutical Industry (Market Focus)
Introduction
The pharmaceutical industry produces increasingly complex products, with reduced time-to-market windows, and stringent domestic and international regulatory and compliance requirements. Datamonitor views PLM technology as one of the most... |
Pharmaceutical Key Trends 2011
Biosimilar Market Overview
In 2009, the combined biosimilars market size for the US and five
major European markets was $150m. With more than 30 branded biologics
with sales of $51bn set to lose... |
Pharmaceutical Research and Development (R&D)
Increasing Efficiency through Information Technology and Externalization
GBI Research's pharma report, 'Pharmaceutical Research and Development (R&D) - Increasing Efficency Through Information Technology and Externalization' provides key data, information and analysis on major pharmaceutical R&D practices at the... |
Big Pharma's Key Lifecycle Management Strategies
Maximizing The Market Potential
GBI Research, the leading business intelligence provider, has released its latest research, "Big Pharma's Key Lifecycle Management Strategies: Maximizing the Market Potential." It provides key data, information and analysis on... |
Industry Dynamics: 2010 Guide to the Asia-Pacific Life Sciences Industry
Introduction
Pharmaceutical companies are expanding into the Asia-Pacific region to increase their market share and reduce costs. The life sciences industry is difficult enough for technology vendors to enter, but add... |
Pharmaceutical Product Lifecycle Management Forecast in North America 2006-2012 (Databook)
Introduction
This databook provides readers with an overview of IT spending on PLM software and services in North America, including the US and Canada.
Scope
Current and projected IT spending on PLM in... |
Streamlining Information in the Pharmaceutical Industry with PLM (Review Report)
Introduction
This report offers insight into PLM in the pharmaceutical industry, bringing together all briefs published for this theme. The report covers market trends, technological components which Datamonitor believes are... |
Pharmaceutical Product Lifecycle Management Forecast in APAC 2006-2012 (Databook)
Introduction
This databook offers a summary of PLM spending in China and Japan from 2006 to 2012
Scope
Current and projected IT spending on PLM in China and Japan
PLM spending splits by software,... |
Trends in Pharmaceutical Portfolio Management
Strategies to Maintain Profitability despite Adversity
Introduction
With growing competition, Pharma companies are under increased pressure to deliver additional value for key stakeholders through their portfolios. Companies with comprehensive portfolios offering more to physicians, patients, payers and... |
2008 Trends to Watch: Pharmaceutical Technology
Introduction
Technology markets are changing fast. This brief identifies and tracks the key forces shaping the prospects for your business. In this piece, Datamonitor's analyst specializing in pharmaceutical technology will outline... |
Product Lifecycle Management (PLM)
This report analyzes the worldwide markets for Product Lifecycle Management (PLM) in US$ Million by the following Product Segments: cPDm, PLM Tools, and Digital Manufacturing Solutions. The report provides separate... |
Directed Molecular Evolution
Product lifecycle management for biologics
Biologics are forecast to be the fastest growing segment of the pharmaceutical market out to 2010 (12.2% CAGR). However, biologics face the emergence of bio-similars and increasing numbers of competitor... |
Pharmaceutical Pricing Compendium
A practical guide to the pricing and reimbursement of medicines
Pricing and reimbursement is one of the most complicated and important business issues that the pharmaceuticals industry has to deal with.
Setting the right price and ensuring that the product is... |
